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ABSTRACT Exchangeable apolipoproteins are located in the surface of lipoprotein particles and regulate lipid metabolism
through direct protein-protein and protein-lipid interactions. These proteins are characterized by the presence of tandem repeats
of amphiphatic a-helix segments and a high surface activity in monolayers and lipoprotein surfaces. A noteworthy aspect in the
description of the function of exchangeable apolipoproteins is the requirement of a quantitative account of the relation between
their physicochemical and structural characteristics and changes in the mesoscopic system parameters such as the maximum sur-
face pressure and relative stability at interfaces. To comply with this demand, we set out to establish the relations among a-helix
amphiphilicity, surface concentration, and surface rheology of apolipoproteins ApoA-I, ApoA-II, ApoC-I, ApoC-II, and ApoC-III ad-
sorbed at the air-water interface. Our studies render further insights into the interfacial properties of exchangeable apolipo-
proteins, including the kinetics of their adsorption and the physical properties of the interfacial layer.
INTRODUCTION
Exchangeable apolipoproteins are found in higher organisms
where they play a central role in the regulation of lipid ex-
change and remodeling. Members of this family are ApoA-I,
ApoA-II, ApoA-IV, ApoA-V, ApoC-I, ApoC-II, ApoC-III,
and ApoE. Human ApoA-I is a protein of 243-amino acid
residues that is significantly associated with high-density li-
poprotein (HDL) particles. ApoA-I promotes cellular cho-
lesterol efflux (1) and interacts with several proteins such as
the scavenger receptor class B type I (2) and the ATP-
binding cassette transporter A1 (3). ApoA-I also exhibits a
protective effect on HDL against coronary artery disease (4)
and is a potent activator of lecithin acyltransferase, the
enzyme that catalyzes cholesterol esterification on HDL (5).
Human ApoA-II associates to form homodimers linked
through a disulfide bridge (6) and forms heterodimers with
ApoE and ApoH (7). ApoA-II down-regulates neutrophil
activity in a similar fashion to ApoA-I (8) and impairs the
antioxidant properties of paraoxonase in HDL particles (9).
The quantification of an ApoA-II isoform has been proposed
as a potential marker for prostate cancer (10), and mutations
in the stop codon of the apoA-II gene, which result in a
carboxyl-terminal peptide extension of 21 amino acid
residues, appear to be responsible for renal amyloidosis (11).
Human apolipoprotein ApoC-I plays a crucial role in the
regulation of apolipoprotein E/b-VLDL particle interaction,
quilomicron uptake, and inhibition of cholesteryl ester
transfer protein (CETP) activity (12). ApoC-I has been as-
sociated with Alzheimer’s disease (13), and there are indi-
cations that ApoC-I polymorphism represents a genetic risk
factor for dementia and for cognitive impairment in the
elderly (14). ApoC-I also accounts for protection from obe-
sity and insulin resistance (15), apoptosis of aortic smooth
cells (16), and lipoprotein clearance (17). ApoC-II activates
lipoprotein lipase and is therefore central for lipid transport
in blood (18). ApoC-III, the most abundant C apolipoprotein
in human plasma, stimulates CETP activity (19) and reg-
ulates plasma triglyceride metabolism (20). In patients with
type 1 diabetes, ApoC-III induces increased cytoplasmic free
intracellular Ca21 concentration and b-cell death (21).
The largest apolipoproteins, ApoA-I and ApoE, display a
repeating pattern of homologous 11- and 22-mer amphi-
pathic a-helical segments that are delineated by proline resi-
dues (22). In comparison, little is known about the structures
of ApoA-IV and ApoA-V, which are also large members of
this protein family. Computational analysis suggests that the
a-helical regions of ApoA-IV are composed of homologous
repeating 11- or 22-mer units, but thoseofApoA-Vare organized
in discrete independently folded domains (23). In contrast to
ApoA-I, ApoA-IV, and ApoE, the three ApoC apolipoproteins
do not form an intramolecular helix-bundle domain but, rather,
a linear arrangement of amphipathic a-helices (22).
The diversity of functions of exchangeable apolipopro-
teins involves their physical contact with lipids and proteins,
including other apolipoproteins. The interaction of apolipo-
proteins with lipids present in the surface of lipoprotein
particles inhibits the activity of transfer proteins such as CETP
(24). However, it has been shown that the interaction between
ApoA-I and ApoA-II regulates the binding of HDL to cells
(25), that ApoC-I is able to displace ApoE from b-VLDL
particles (26), and that the masking of the receptor domain of
ApoB by ApoC-III inhibits the binding to LDLR (27).
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Several studies on isolated apolipoproteins at interfaces
have been reported in recent years (28–33). However, it has
been difficult to evaluate with certainty the relative surface
activity of these proteins for various reasons: 1), the exact
locations and boundaries of the a-helices of various apolipo-
proteins were determined with certainty until very recently;
2), different studies reported different amphiphilicity scales
for amino acid residues; and 3), the diversity of experimental
conditions such as pH, temperature, protein concentra-
tion, and subphase composition involved in those studies
makes bona fide comparisons among apolipoproteins diffi-
cult. Hence, we set out to establish the adsorption kinetics,
stability, and rheology of exchangeable apolipoproteins at
air-water interfaces using state-of-the-art techniques such as
surface rheology and null-ellipsometry coupled to Brewster
angle microsocopy (BAM). We establish that the surface
activity of exchangeable apolipoproteins increases as fol-
lows: ApoA-I, ApoA-II, ApoC-I, ApoC-II, and ApoC-III
and that the kinetics of adsorption, surface rheology, and
stability correlate well with the amphiphilicity of a-helix
segments. We anticipate that the same physicochemical
properties that rule the adsorption of exchangeable apolipo-
proteins onto monolayers also govern their adsorption onto
the surface of lipoprotein particles.
MATERIALS AND METHODS
Materials
All of the oligonucleotides described in this work were synthesized in the
Protein and Nucleic Acid Chemistry facility at the Department of Bio-
chemistry, University of Cambridge, UK. All polymerase chain reactions
(PCR) were performed with PfuTurbo DNA polymerase (Stratagene,
Stratagene Europe, Amsterdam, The Netherlands) using a PTC-100 Thermal
Cycler (MGE,). The amplicon was cloned in a pRSET-A vector (Invitrogen,
Carlsbad, CA) under control of the T7 promoter. This vector also contains
the encoding sequence of a tandem of six N-terminal histidine residues
followed by a thrombin cleavage site (GLVPRG). The identity of
recombinant ApoC-I was confirmed by mass spectrometry (MALDI-TOF)
and N-terminal sequence analysis according to the Edman degradation
technique. Human TPR-PP5(16-181) and ApoC-I were expressed in E. coli
BL21 Codon plus. BUB1 and BUBR1 protein constructs were expressed in
E. coli BL21 (DE3) as GST fusions. Both bacteria strains were from
Stratagene (La Jolla, CA). Human apolipoproteins ApoA-I, ApoA-II, ApoC-I,
ApoC-II, and ApoC-III isolated from human serum and of a purity of;90%
were obtained from Calbiochem (Calbiochem, Merck Chemicals Ltd.
Nottingham, UK). Expression vector pGEX4T-1, high-purity thrombin, and
the chromatography columns XK 26, Superdex 75 Hiload 26/60, Sepharose
glutathione fast flow, and benzamidine fast flow were obtained from
Amersham Pharmacia (Uppsala, Sweden). Ni-NTA resin was from Qiagen
(West Sussex, UK). Tablets of a cocktail of protease inhibitors were from
Boehringer Mannheim (Roche Diagnostics, East Sussex, UK). A French press
was used for cells rupture (SIM-Aminco, Rochester, NY). Benzamidine,
imidazole, and all the salts used for preparing buffer solutions were obtained
from Sigma (St. Louis, MO). Buffer and protein solutions were prepared
with ultrapure water (Nanopure-UV, Barnstead, Dubuque, IA). Dialysis was
carried out using a regenerated cellulose dialysis membrane of 3500MWCO
(Spectra/Por; Spectrum Lab., Rancho Dominguez, CA). Quartz cells for
circular dichroism (CD) were from Hellma (Essex, UK).
Methods
Synthesis of the ApoC-I encoding sequence
The set of overlapping oligonucleotides designed for the synthesis in vitro of
the full-length, human ApoC-I encoding sequences were named as follows:
Oligo apoC1-1: 59 GTATGCTGTCACGGATCCACCCCAGACGTCTC-
CAGCGCCTTGGATAAGCTGAAGGAGTTTGGTAC 39; Oligo apoC1-2: 59
TAGTTGAGGTCCGAATTCTTAT TAAGAGTCAATCTTGAGTTTCT-
CCTTCACTTTCTGAAATGTCT 39; Oligo apoC1-3: 59 TGAGTTTCTC-
CTTCACTTTCTGAAATGTCTCAGAAAACCACTCA CGCATCTTGG-
CAGAAAGTTCGCTCTGTTTGATGCGGCTGATG 39; Oligo apoC1-4:
59GGATAAGCTGAAGGAGTTTGGTAACACACTGGAGGACAAGGC
TCGTGAACTCATCAGCCGCATCAAACAGAGCGAACTTTCT 39; Oligo
apoC1-5: 59 GTATGCTGTCACGGATCCACCCCAGACGTCTCTAGC 39;
Oligo apoC1-6: 59 TAGTTGAGGTCCGAATTCTTATTAAGAGTCAAT-
CTT 39; Oligo apoC1-7: 59 GTATGCTGTCACGGATCCACCCCAGAC-
GTCTCTAGC 39; and apoC1-8: 59 TAGTTGAGGTCCGAATTCTTAT-
TAAGAGTCAATCTT 39. Some minor modifications were introduced into
the original human encoding sequence to optimize its expression according
to the preferential codon usage in E. coli. Nested PCR was carried out for the
synthesis of the human ApoC-I encoding sequence according to the fol-
lowing PCR program: segment 1, 30 s at 95C; segment 2, 1 min at 55C,
and segment 3, 4 min at 68C, 18 cycles. The pRSET-A vector was double-
digested with the restriction enzymes BamHI and EcoRI to clone the tailored
human ApoC-I encoding sequence immediately downstream from the co-
dons encoding for the residues HHHHHHGLVPRG.
Protein expression and puriﬁcation
Recombinant ApoC-I was expressed using conventional protocols. Briefly,
cells were grown at 37C, 250 rpm in 23 TY broth containing ampicillin.
Induction was done using IPTG at cell densities of 0.6–0.8 OD600 nm.
Inclusion bodies were resuspended in denaturing buffer (i.e., Tris buffer 20
mM containing 8 M urea, 25 mM imidazole, and 5 mM b-mercaptoethanol,
pH 8.0), and 100 ml of denaturing buffer was used per 2 g of inclusion
bodies. The resulting solution was loaded onto an XK 26 column packed
with 12 ml of Ni-NTA agarose previously equilibrated in the same buffer
solution. After being washed with ;20 column volumes, recombinant
ApoC-I was refolded into the column, concentrated, loaded onto a gel
filtration column (Superdex 75, HR 26/60), and eluted in 20 mM Tris buffer,
200 mM NaCl, pH 8.0 (TBS buffer) at 1 ml/min. After analysis by SDS-
PAGE and measurement of UV absorption spectra (200–300 nm), fractions
containing pure ApoC-I were collected and concentrated. Refolded ApoC-I
was subjected to thrombin cleavage after extensive dialysis in TBS. One unit
of thrombin protease of high purity was used to digest 1 mg of recombinant
ApoC-I at 4C overnight. Thrombin and the cleaved histidine tag were
removed using a benzamidine fast flow column and a Ni-NTA column,
respectively, previously equilibrated in TBS. Pure recombinant ApoC-I was
concentrated fivefold and dialyzed several times against 4 liters of dialysis
buffer (20 mM ammonium bicarbonate buffer, pH 8.0), lyophilized, and
stored at 20C. N-terminal sequence and mass spectrometry were carried
out to confirm protein identity and purity of recombinant ApoC-I.
Every protein described in this study was subjected to gel filtration
chromatography (Superdex 75, HR 26/60; TBS buffer as the mobile phase)
to remove any oligomer of high molecular mass and to maintain protein
samples in the same buffer solution. In all of the cases, gel filtration
chromatography was performed immediately before experiments in mono-
layers.
Ellipsometry and BAM
Monolayers were prepared on a circular trough (S¼ 20 cm2), and the surface
pressure was measured with a sensor (Nima Technology, Coventry, UK)
using a Wilhelmy plate. The ellipsometric measurements were carried out
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with a home-made ellipsometer (34) operated with He–Ne laser (l ¼ 632.8
nm, Melles Griot, Carlsbad, CA) that was polarized with a Glan-Thompson
polarizer. The incidence angle of the light on the surface was 1 away from
the Brewster angle. After reflection on the water surface, the laser light
passed through a l/4 retardation plate, a Glan-Thompson analyzer, and
a photomultiplier. Through a computer-controlled feedback loop, the ana-
lyzer automatically rotated toward the extinction position. In this ‘‘null
ellipsometer’’ configuration (35), the analyzer angle, multiplied by 2,
yielded the value of the ellipsometric angle (D), i.e., the phase difference
between parallel and perpendicular polarization of the reflected light. The
laser beam probed a surface of 1 mm2 and a depth of the order of 1 mm. The
ellipsometric angle D is proportional to the quantity of protein adsorbed at
the interface in the case of a monolayer. Hence, the variation of the
ellipsometric angle is a relevant probe for changes occurring at the interface.
By use of the measured ellipsometric angle, D, and an estimate of the
refractive index increment of the protein to 0.2 ml/g, the surface con-
centration G of adsorbed protein was calculated using the relation between D
and G reported by De Feijter et al. (36). Initial values of the ellipsometric
angle (D0) and surface tension of pure buffer solutions were recorded on the
subphase for at least a half-hour. These values have been subtracted from all
data presented below. Values of D and surface pressure (p) were stable and
recorded every 4 s with a precision of 60.5 and60.5 mN/m, respectively.
BAM was performed in a homemade device with a spatial resolution
;4 mm. In this setup, the interface is illuminated at the Brewster incidence
(ﬃ 53) with a polarized beam from a He-Ne laser. A microscope receives
the reflected beam and the signal transmitted to a CCD video camera to
develop an image of the monolayer. Protein concentrations used for
ellipsometry, surface pressure measurements, and BAM observations were
in the range 1–80 mg/ml in 20 mM sodium phosphate buffer, pH 7.0.
Surface rheology
The principles and implementation of our experimental setup for the
measurement of the lateral rigidity of monolayers and the procedure for data
analysis have been extensively described before (37,38). Briefly, at the
center of a 48-mm-diameter Teflon trough, a 10-mm-diameter paraffin-
coated aluminum disk floats at the air-water interface, in contact with the
monolayer whose rigidity is measured. The subphase is 5 mm deep. The
float carries a small magnet and is kept centered by a permanent magnetic
field, B0 ¼ 6 3 105 T, parallel to the Earth’s field and created by a small
solenoid located just above the float. Sensitive angular detection of the float
rotation is achieved using a mirror fixed on the magnet to reflect a laser beam
onto a differential photodiode. A sinusoidal torque excitation is applied to
the float in the 0.01- to 100-Hz frequency range by an oscillating field
perpendicular to the permanent solenoid field. The latter field acts as a
restoring torque equivalent to a monolayer with a rigidity of 0.16 mN/m.
This number set the sensitivity limit of the rheometer. The device behaves as
a simple harmonic oscillator. The resistance that the monolayer opposes to
the rotation of the float is directly measured. An important advantage of this
setup is the absence of physical link between the outside and the float torsion
(i.e., no torsion wire). This allows high sensitivities such that the applied
deformation is very small, below uxy  107 where uxy corresponds to the
deformation tensor. This device introduces very small excitation strains
(from 103 down to 106) to the system. Because in previous experiments
we have shown that pure shear elastic response spectra exhibit a linear stress-
strain relation over this range (37), we concluded that the rotation coupling
between the float and the contacting monolayer is satisfactory. Moreover, we
have shown that such small strains do not create plastic deformations on
fragile surface objects (38).
For the experimental procedure, the amplitude and phase of the
mechanical response of the pure subphase were first analyzed in the
frequency range 0.01–100 Hz to establish that no rigidity was detected. This
measurement takes approximately 1 h. Then, the protein solution was
directly poured in the trough, and the mechanical response of the layer
formed at the interface was recorded at the fixed frequency of 5 Hz. At the
end of the adsorption kinetics, when the shear elastic constant, m (expressed
in mN/m) reached a constant value, a new measurement between 0.01 Hz
and 100 Hz was recorded to determine whether the system behaves as an
elastic layer. Rigidity measurements were carried out in parallel to
ellipsometry. All of the experiments were performed at 18C.
RESULTS
Expression and puriﬁcation of the human ApoC-I
encoding sequence
Single nucleotide substitutions introduced in the synthetic
ApoC-I encoding sequence to avoid the problem of codon
bias were adequate as ApoC-I was overexpressed in the
eubacteria E. coli, and the amino acid sequence of this
protein was confirmed to be identical to that deposited in the
Entrez Protein database (Access number P02654). Recom-
binant human ApoC-I thus expressed formed inclusion
bodies but was efficiently refolded when bound to metal
affinity chromatography columns. The strategy used consists
of a decrease of urea concentration (typically from 6 M to 5
M) followed by a fast increase from 5 M to 5.5 M; then, a
second decrease (from 5.5 M to 4.5 M), a new reincrease
from 4.5 M to 5 M, and so on until urea was completely
depleted from the column and replaced by 20 mM Tris buffer
containing 10 mM b-mercaptoethanol, pH 8.0. Refolded
recombinant ApoC-I and that isolated from human serum
exhibited identical secondary structure content as determined
by far-UV circular dichroism (data not shown). Previous
reports on the CD spectroscopy analysis of several ex-
changeable apolipoproteins, including ApoC-I (39), ApoA-
II (40), ApoA-I, and ApoC-III (31), have shown that these
proteins do not show a concentration-dependent signal in the
concentration range 107 M to 106 M. In addition, dynamic
light-scattering studies on ApoA-I self-association have
shown that this protein can form oligomers of higher orga-
nization at concentrations above 1 mg/ml (41).
Exchangeable apolipoproteins form
stable monolayers
The molecular mass of exchangeable apolipoproteins varies
as follows: ApoC-I, 6.6 kDa; ApoC-III, 8.7 kDa; ApoC-II,
8.9 kDa; ApoA-II, 17 kDa; and ApoA-I, 28 kDa. Solutions
of ApoA-I at molar subphase concentrations ranging from
108 M to 106 M and of ApoA-II, ApoC-I (native and
recombinant), ApoC-II, and ApoC-III at concentrations of
107 M and 106 M were used to characterize the interfacial
properties of these proteins under identical experimental
conditions. As shown in Fig. 1 A, exchangeable apolipopro-
teins rapidly adsorb at the interface (less than 20 min at the
same subphase concentration of 106 M), leading to a
maximal surface pressure between 22 to 26 mN/m. Not
surprisingly, recombinant ApoC-I and that isolated from
human serum exhibited similar adsorption kinetics (see inset
of Fig. 1). For this reason, in the following sections only the
series of studies conducted on recombinant ApoC-I are
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presented. Null ellipsometry measurements recorded at the
same molar subphase concentration (i.e., 106 M) indicated
that similar amounts of ApoA-I, ApoA-II, ApoC-I, ApoC-II,
and ApoC-III were adsorbed at the air-water interface (i.e.,
;1.56 0.25 mg/m2) (Fig. 1 B). However, the time necessary
to reach the interface and form a stable layer greatly varied
among exchangeable apolipoproteins: for ApoC-I it was 30
min; for ApoA-I, 1 min; ApoA-II, 15 min; ApoC-II, 15 min;
andApoC-III, 25min. Consistent with null ellipsometry mea-
surements, direct BAM observations showed that ApoA-I,
ApoA-II, ApoC-I, ApoC-II, and ApoC-III were rapidly
adsorbed at the interface and formed homogeneous layers at
the BAM resolution (4 mm) (Fig. 2). The maximal surface
concentration of these apolipoproteins (expressed in mg/m2)
is lower than that of small, all-a-helix protein domains
containing other classes of tandem repeats such as the
tetratricopeptide (TPR) motifs of human protein phosphatase
5 (PP5) (4.7 mg/m2) and human BUBR-1 (3.5 mg/m2) (42).
In addition to being surface active, the direct comparison
among these proteins is pertinent because the molecular
masses of TPR-PP5 (19 kDa) and TPR-BUBR-1 (27 kDa)
are approximately the same as those of ApoA-II and ApoA-I,
respectively.
FIGURE 1 (A) Surface pressure and (B) surface concentration (referred to
as Gmax) as a function of time of exchangeable apolipoproteins at the
subphase concentration of 106 M. Open squares, ApoC-I; open circles,
ApoA-I; solid circles, ApoA-II; solid triangles, ApoC-III; crosses, ApoC-II.
(Insets) Comparison of native (open squares) and recombinant (solid
squares) ApoC-I at the subphase concentration of 107 M.
FIGURE 2 BAM images of exchangeable apolipoproteins at the air-water
interface after 5 h of adsorption at the subphase concentration of 106 M.
(Left) Control (buffer); (right) protein. (A) ApoC-I; (B) ApoA-I; (C) ApoA-
II; (D) Apo-CIII; (E) ApoC-II.
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The surface concentration, Gmax, of exchangeable apolipo-
proteins was studied at the subphase concentrations of 106
M to estimate the number of molecules adsorbed at the
interface (Fig. 3). As Fig. 3 shows, Gmax (expressed in mol/
m2) seems to be inversely proportional to the molecular
mass: the smallest proteins, ApoC-I, ApoC-II, and ApoC-III,
show more molecules adsorbed at the interface than ApoA-I
and ApoA-II.
The evolution of the surface pressure versus the subphase
concentration for ApoA-I (Fig. 4) is typical of amphiphilic
molecules: at low subphase concentrations, the surface
pressure increases with subphase concentration up to a
critical value for which the surface is saturated (43,44). Then,
one of two scenarios can occur: 1), either the protein forms a
stable interfacial monolayer and no more molecules adsorb
beneath the interface (in which case the surface pressure and
the ellipsometric angle are constant); or 2), additional
molecules can adsorb in a reversible manner beneath the
surface. In this case, the ellipsometric angle increases while
the surface pressure remains constant (44). Our experiments
do not shed light on which of the two processes takes place
because ellipsometric measurements have not been per-
formed on a wide subphase concentration range. However,
we can assert that the surface is saturated because the surface
pressure of ApoA-I (22 mN/m) does not depend on subphase
concentrations above 107 M. For the other apolipoproteins,
ellipsometric measurements have been carried out at the
subphase concentrations of 107 M and 106 M. The surface
pressure at the end of adsorption kinetics is nearly the same
at these two subphase concentrations (Fig. 4, inset), sug-
gesting that the plateau value of the surface pressure has been
reached and the surface is saturated.
Kinetics of adsorption at interfaces
Adsorbed surface concentration and surface pressure were
recorded at the low protein concentration of 3 mg/ml to
follow the first adsorption events and to extract several
parameters relevant to the surface activity. Two of these
parameters were obtained from the plot of G versus p (Fig.
5). Here, G0 is the surface concentration at which the surface
pressure becomes different from zero. u is extracted from the
slope of the G-p curve (i.e., Dp/DG) and corresponds to the
increase of surface pressure relative to the increase of surface
concentration (45).
In contrast to Gmax, which is similar in all of the cases
(expressed in mg/m2), G0 varies greatly: for ApoA-I, G0 ¼
0.6mg/m2; ApoA-II,G0¼ 1.2mg/m2; ApoC-I,G0¼ 1.1mg/m2;
ApoC-II, G0 ¼ 0.8 mg/m2; and ApoC-III, G0 ¼ 1.1 mg/m2
(Fig. 5). When the ratio Gmax/G0 is close to 1 (i.e., Gmax is
slightly higher than G0), it suggests that as soon as the surface
coverage is sufficient to initiate nonnull surface pressure,
only a few more molecules adsorb onto the film. On the
contrary, a higher Gmax/G0 ratio indicates that molecules find
a place at the interface once the surface coverage has been
initiated. This behavior can be attributed to protein confor-
mational changes at the interface such that molecules occupy
the remnant surface available. The ratio Gmax/G0 is equal to
2.7 in the case of ApoA-I (Fig. 3), which is comparable,
under the same experimental conditions, to that of other
surface-active proteins such as BUBR-1 and b-casein
(42,46). This ratio is much lower for other exchangeable
apolipoproteins (ranging between 1.9 and 1.2) and follows
the decreasing order: ApoC-II . ApoC-III . ApoC-I .
ApoA-II. Moreover, the high value of u (higher than 33
mNm/mg) compared with other surface-active proteins (45)
indicates that extensive lateral interactions occur when the
surface cover becomes effective (i.e., when G . G0). This
parameter further indicates that exchangeable apolipopro-
teins belong to a group of highly surface-active proteins.
In the first steps of adsorption kinetics at low bulk con-
centration, the transport of apolipoprotein molecules from
the subphase to the interface is assumed to be a diffusion-
controlled process. Therefore, the surface concentration G
follows the relation of Ward and Tordai (47) (Eq. 1):
G ¼ 2CbðDt=3:1416Þ½; (1)
where G is the surface concentration (mg/m2), Cb is the
subphase concentration (mg/m3), and t the time (s). The
initial part of the G-t½ plot shows a linear correlation (Fig. 6),
making possible the calculation of the diffusion coefficient,
D. As shown in Table 1, ApoA-I, ApoA-II, ApoC-I, ApoC-
II, and ApoC-III all have a diffusion coefficient of the same
order of magnitude (i.e., of the order of 1010 m2/s) as that
reported for other globular proteins of a similar size (36).
Surface rheology reveals the formation of
rigid monolayers
The mechanical behavior of monolayers of exchangeable
apolipoproteins at the air-water interface was investigated at
FIGURE 3 Apolipoprotein surface concentration (expressed in mol/m2).
Solid bars correspond to the maximal surface concentration (Gmax) reached
at the end of the adsorption kinetics at the subphase concentration of 106
M. Hatched bars correspond to G0, the minimal surface concentration
necessary to initiate surface pressure (see Fig. 5 for the determination of G0).
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the fixed frequency of 5 Hz and subphase concentrations
within the range 107–106 M. Even at the lowest subphase
concentration (i.e., 3 mg/ml), the final shear elastic constant,
m, reached high values. It is important to mention, for the
fair comparison of the interfacial rheology of exchangeable
apolipoproteins at the end of the adsorption kinetics, that
triplicate experiments showed a variation of the absolute
magnitude of this constant of up to 20%. Nevertheless, the
study of the evolution of the shear elastic constant as a
function of time clearly shows that molecules reaching the
interface self-organize to form a cohesive layer (Fig. 7).
At the end of each adsorption kinetics (around 10 h, indicated
by the arrow in Fig. 7), the amplitude and phase of the
mechanical response of the monolayer were analyzed in the
frequency range 0.01–100 Hz. For each exchangeable
apolipoprotein, the real and imaginary part of the response
adjusted well to an elastic layer model (i.e., a simple
harmonic oscillator), as shown in the inset of Fig. 7. This
indicates that medium- and long-range interactions play a
major role in the cohesion of the layer. During the first hours,
the kinetics of the formation of the interfacial layer is similar
for all apolipoproteins. However, once the interfacial layer is
formed, the interfacial behavior differs in each case: ApoC-II
reaches a plateau around 22 mN/m over the first 5 h, which is
FIGURE 4 Surface pressure of ApoA-I reached at the
end of the adsorption kinetics as a function of subphase
concentration. (Inset) Surface pressure of other exchange-
able apolipoproteins at the two subphase concentrations
indicated by the arrows: 107 M (hatched bars) and 106
M (solid bars).
FIGURE 5 Estimation of G0 and u of exchangeable apolipoproteins
calculated from the adsorption kinetics at the subphase concentration of 3
mg/ml, pH 7. (Open squares) ApoC-I; (open circles) ApoA-I; (solid circles)
ApoA-II; (solid triangles) ApoC-III; (crosses) ApoC-II.
FIGURE 6 Surface concentration G (mg/m2), as a function of the square
root of time, t½, (h½). (Open squares) ApoC-I; (open circles) ApoA-I; (solid
circles) ApoA-II; (solid triangles) ApoC-III; (crosses) ApoC-II. In the first
part of the kinetic adsorption at low subphase concentration the process is
diffusion controlled. Hence, the surface concentration obeys the law: G ¼
2Cb(Dt/3.1416)
½. The slope of the curve G versus t½ (shown on the graph in
case of ApoC-III) gives the value of the diffusion coefficient, D (m2/s1).
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followed by a steady decrease of rigidity (about 6 mN/m
over 6 h). In contrast, ApoA-I shows a plateau at;20 mN/m
up to 10 h, suggesting that no further major reorganization
occurs in the monolayer. After the formation of the layer,
the rigidity of ApoC-III increases slightly but regularly (;8
mN/m over 12 h), and ApoC-I and ApoA-II show a similar
behavior: after initial adsorption, m rapidly increases (;12
mN/m and 22 mN/m, respectively) and reaches a plateau
after 8 h (m ¼ 38 mN/m and 48 mN/m, respectively).
DISCUSSION
In previous reports (30,31), we have discussed the fact that
the preferred protein conformations that exchangeable
apolipoproteins adopt when deposited at the interface are
those where the amphipathic a-helices lay horizontally on
the aqueous subphase. Such interfacial organization permits
these proteins to travel on a landscape of close energy
minimum configurations (31,48). Indeed, recent studies on
ApoA-I have shown that many (if not all) of the functions of
lipid-free and HDL-bound ApoA-I arise from its various con-
formational states (49,50), whereas the three-dimensional
structure of human ApoC-II in complex with sodium dodecyl
sulfate (SDS) micelles has shown that flexibility of the
C-terminal helix is required for the activation of lipoprotein
lipase (18). Besides, the crystal structures of ApoA-I (51)
and ApoA-II (52), the NMR structure of ApoC-I (53) and
ApoC-II (54), as well as the structural model of ApoC-III
(22) show that these proteins present few conformational
constraints. These common features suggest that exchange-
able apolipoproteins require a flexible and adaptable struc-
ture to carry out the multiplicity of their functions (22,55).
TABLE 1 Comparison of the maximal surface pressure and rheological properties of exchangeable apolipoproteins
Protein
Max. surface
pressure (mN/m)
Max. surface
conc. (mg/m2)
Diff. coeff.
(31010 m2/s)
Max. m
after 15 h u (mNm/mg) G0 (mol/m2)
ApoA-I 22.5 1.6 0.9 22 40 2.1 108
ApoA-II 23 1.5 1.8 48 33 7 108
ApoC-I 23.5 1.5 1.5 38 41 1.7 107
ApoC-II 25 1.5 0.4 12 37 9 108
ApoC-III 26.5 1.5 6.3 28 41 1 107
FIGURE 7 Shear elastic constant, m, as a func-
tion of time of exchangeable apolipoproteins at the
subphase concentration of 3 mg/ml. (Open squares)
ApoC-I; (open circles) ApoA-I; (solid circles)
ApoA-II; (solid triangles) ApoC-III; (crosses)
ApoC-II. The end of the adsorption kinetics (;10 h)
is indicated by the arrow. (Inset) The mechanical
response of the layer at the end of the kinetic
interval was recorded as a function of the pulsation
v. The imaginary and real parts of the response
adjust well to a harmonic oscillator, indicating that
the monolayer fits an elastic layer model. For
clarity, the imaginary part has been plotted versus
v. The curves correspond to ApoA-I and are
representative of the other exchangeable apolipo-
proteins.
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The interfacial maximal surface pressures of ApoA-I,
ApoA-II, ApoC-I, ApoC-II, and ApoC-III are comparable to
that of a de novo peptide ((PLAEELRARLRAQLEEL-
RERLG)2-NH2) designed on the basis of the amino acid
residue conservation of the amphipathic a-helices of ApoA-I,
ApoA-IV, and ApoE (56). The putative apolipoprotein
peptide showed a maximal surface pressure in the range 24 to
27 mN/m at the same concentration of 106 M. However,
compared with this consensus sequence peptide, the ex-
changeable apolipoprotein ApoA-I proved to be more flexi-
ble at the interface (57), supporting the idea that flexibility
and surface pressure-mediated desorption and readsorption
of ApoA-I confer lipoprotein stability during metabolic re-
modeling reactions (57).
Although exchangeable apolipoproteins show a common
rapid adsorption at interfaces and formed stable monolayers,
important differences in the interfacial behavior of these
proteins were noticed. For instance, when surface pressure
has initiated (G ¼ G0), nearly two times more ApoA-I mole-
cules than any other apolipoprotein were adsorbed at the
interface until the condition where G ¼ 2.7 G0, suggesting
that once the first molecules adsorb at the interface (inducing
a nonnull surface pressure) some surface remains available
for the adsorption of additional molecules. In contrast, when
lateral interactions were established between molecules in
ApoA-II, ApoC-I, and ApoC-III monolayers, a few more
molecules could be adsorbed at the interface (G ¼ 1.5G0).
This observation correlates well with the relatively few con-
formational constraints of the latter group, which leads to the
complete covering of the surface once these exchangeable
apolipoproteins have sampled a larger conformational space.
The different adsorption kinetics of exchangeable apolipo-
proteins evidences the fundamental role of a-helix amphi-
philicity in the determination of interfacial properties. Equation
2 shows that a-helix amphiphilicity can be estimated from
the magnitude of the hydrophobic moment, mH (58), as
follows:
mH ¼ 1=N ½½+
n¼1
Hn sin ðdnÞ2 1 ½+
n¼1
Hn cos ðdnÞ2½; (2)
where dn corresponds to the angle formed between amino
acid lateral chains of two adjacent residues with respect to
the plane of the a-helix (for an ideal a-helix, d¼ 100); N¼
the number of residues in that a-helix; and Hn, the numerical
hydrophobicity of the nth residue, corresponds to a theoret-
ical value of the degree of partition of an amino acid between
the surface and the interior of a globular protein. a-Helical
regions with mH values higher than 0.2 kcal/mol per residue
are considered good amphipathic a-helices. As Table 2 shows,
the first a-helix of ApoC-I (residues 13–25) exhibits a higher
hydrophobic moment value (mH ¼ 0.51 kcal/mol per residue)
than the second one (residues 37–52) (mH ¼ 0.46 kcal/mol
per residue). The high amphiphilicity of the a-helix segments
of ApoC-I explains how the smallest of the exchangeable
apolipoproteins reported to date is able to displace a larger
apolipoprotein molecule such as ApoE from b-VLDL par-
ticles (26). Similarly, the displacement of ApoA-I by ApoA-II
from HDL particles (59) can be explained considering the
higher average a-helix amphiphilicity (mHavg ¼ mHi =ni) of
ApoA-II (mHavg 0.48 kcal/mol per residue) compared with that
of ApoA-I (mHavg ¼ 0.38 kcal/mol per residue). Even though
the high surface activity of exchangeable apolipoproteins is
largely determined by the overall a-helix amphiphilicity,
other properties such as self-association, which varies greatly
among exchangeable apolipoproteins, may affect the rate
at which these proteins move from the bulk toward the
interface. For instance, in its lipid-bound conformation,
ApoA-I can self-associate and form dimers in a process that
involves intramolecular interactions between the N-terminal
and C-terminal ends (60). Such self-association also seems to
TABLE 2 Values of mH/residue of amphipathic a-helical regions of exchangeable apolipoproteins
Protein
Number of residues/molecular
mass (kDa) PDB access No.
Residues involved in a-helix
formation mH/residue (kcal/mol) mHavg (kcal/mol)
ApoA-I 243/28.3 2A01 10–39 0.44 0.39
50–83 0.43
97–116 0.45
121–137 0.39
146–187 0.28
196–213 0.38
219–241 0.31
ApoA-II 77/8.7 1L6K 8–32 0.51 0.48
56–71 0.45
ApoC-I 57/6.6 1IOJ 13–25 0.51 0.49
37–52 0.47
ApoC-II 79/8.9 1SOH 14–35 0.45 0.35
62–76 0.25
ApoC-III 79/8.7 Structure model (22) 8–36 0.43 0.42
41–71 0.41
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account for the stable interaction of ApoA-I with HDL
particles (60,61). We show that the maximal surface activity
of ApoA-I and ApoA-II is comparable to that reported by
others (ApoA-I, 22 mN/m (32); ApoA-II, 24 mN/m (32)) but
differs significantly from the value described in other reports
(ApoA-I, 32 mN/m (29); ApoA-II, 34 mN/m (62)). Overall,
the discrepancy reflects the different conditions (pH, tem-
perature, etc.,) in which the experiments were carried out. In
the case of ApoC-I, ApoC-II, and ApoC-III, no comparison
with other publications can be made because, to the best of
our knowledge, this is the first report in which the interfacial
behavior of the three human apolipoproteins is described.
A previous study on compressed monolayers of ApoA-II
suggested that this apolipoprotein is predominantly stabilized
at the air-water interface through short-range interactions (63).
Clearly, the study of the evolution of m as a function of time
for ApoA-II and other exchangeable apolipoproteins (Fig. 7)
challenged that notion. The discrepancy seems to originate
from the technical limitations of the experimental setup de-
scribed in that report. Indeed, Ruiz-Garcia et al. (63) noticed
the contamination of transferred ApoA-II monolayers with
potassium chloride crystals and recognized that AFM ob-
servations were difficult to interpret and led to inconsistent
estimations of the unit cell dimensions. In contrast, our setup
permits the monitoring of changes in the rheology of the
protein at the interface without further manipulation of the
system. The high magnitude of m (.20 mN/m) with regard
to the low bulk concentration (3 mg/ml) and the satisfactory
fit to an elastic model strongly suggest the establishment of
medium-range and long-range interactions between exchange-
able apolipoproteins when they are deposited onto mono-
layers. Although we observed that ApoA-I, ApoA-II, ApoC-I,
ApoC-II, and ApoC-III monolayers exhibit different evolu-
tion of the shear elastic constant, in all of the cases stable,
relatively rigid films were formed after a few hours. Inter-
estingly, medium- and long-range interactions are recognized
to play an important role in the reshape of ApoA-I-containing
lipoprotein particles from discoidal to spherical structures in
vitro (64) and may contribute to the confinement of ApoA-II
monomers to the circumference of discoidal lipoprotein par-
ticles in vivo (65). Moreover, the conformational constraints
of adjacent amphipathic a-helices of ApoA-I Milano im-
posed by these classes of interactions seem to explain the fact
that this isoform is twice as effective as ApoA-I Paris in
protecting phospholipids from oxidation (66).
These observations suggest that some of the physico-
chemical parameters that govern the behavior of apolipo-
protein monolayers influence protein function. Independent
studies on ApoA-I and ApoA-II have shown that the stoi-
chiometry of displacement of ApoA-I by ApoA-II at flat lipid
monolayers spread at the air-water interface and at the sur-
faces of HDL and lipid-protein complexes is similar (33,67).
However, rheological measurements on ApoA-I adsorbed
under lipidic layers have demonstrated that the presence of
ApoA-I in a lipidic layer does not increase the rigidity of the
latter, suggesting that this apolipoprotein does not establish
the same long-range interactions in the presence of lipids as
it does at the air-water interface (S. Beaufils, V. M. Bolanos-
Garcia, and M. Pinot, unpublished results). Thermal denatur-
ation and far-UV CD spectroscopy on several exchangeable
apolipoproteins associated with HDL particles have shown
that such association decelerates protein unfolding by at least
10 orders of magnitude compared with the lipid-free form
(39). In addition, it seems that the molecular determinants of
the stability of exchangeable apolipoproteins under physio-
logical conditions and those of monolayers of isolated
proteins might be different and likely to involve high kinetic
barriers (39). Hence, the study of lipid-free exchangeable
apolipoproteins deposited onto monolayers is insufficient to
fully describe the behavior observed under physiological
conditions. Nevertheless, the characterization of the surface
rheology of monolayers of exchangeable apolipoproteins sup-
ports the idea that medium-range and long-range interactions
are the main stabilizing forces in all a-helix proteins compared
with those involved in the stabilization of the structural classes
all-b, a1b, and a/b (68). Surface rheology measurements
show that monolayers of exchangeable apolipoproteins are
comparably less rigid than those of the TPR motifs of PP5 and
BUBR-1, which is in good agreement with the lower con-
formational constraints of the former group and their hallmark
property of exchange between lipoprotein particles.
Our study provides insights into the adsorption kinetics,
surface activity, and rheology of exchangeable apolipoproteins
and the relation between these properties and their physio-
logical functions. We also show the importance of medium-
range and long-range interactions among amphipathic a-helix
segments for the stability of these proteins at air-water in-
terfaces. Further insight into the nature of medium- and long-
range interactions between proteins in the interfacial layer
could be brought by PM-IRRAS experiments, giving in-
formation on the conformation of proteins at the interface
during their adsorption and once the layer is formed. Such
studies are currently in progress. Because it will be par-
ticularly important to generate information on the interfacial
properties of exchangeable apolipoproteins in the lipid-
bound state, future work will seek to study ApoA-I, ApoA-II,
ApoCI, ApoC-II, and ApoC-III deposited onto lipid-water
monolayers.
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